HtmlToText
go to menu go to content aa contrast enhancement fr en accelerating progress to face cancers follow us : × déconnexion êtes-vous sûr de vouloir vous déconnecter ? annuler se déconnecter home the french national cancer institute the french national cancer institute the cancer plan 2014-2019 osiris : a national data sharing project date of last update : 27/10/2017 -- the french national cancer institute last updated: 30/05/2016 the french national cancer institute (inca) is the preeminent health and science agency in charge of cancer control in france, c reated under the public health act of 9th august 2004. it reports to the ministries for health and for research. the institute is a public interest grouping (gip) which brings together state representatives, charities, health insurance funds, research organisations and hospital federations. these stakeholders share a common goal of reducing the incidence of avoidable cancers and the number of cancer deaths, improving the quality of life of people with cancer during and after their illness, and reducing inequalities related to cancer. the institute provides an integrated approach encompassing all cancer-control dimensions (health, scientific, social and economic) and areas of intervention (prevention, screening, care and research) for the benefit of patients and their relatives. to catalyse progress, the inca acts as an interface with patients, their friends and families, the healthcare system users, general public, healthcare professionals, researchers, experts and decision-makers. the institute is responsible for rolling out the 2014-2019 cancer plan . our missions to provide an integrated approach to cancer control; to spur innovation; to produce evidence-based guidelines for decision-makers and professionals; to coordinate regional oncology networks; to analyse data to guide action more effectively; to disseminate knowledge about cancer. our strategic goals research to support emerging fields, i.e. genomic studies, experimental study models, biology and immunology; to translate fundamental discoveries into advances for the benefit of the population and for patients — diagnostic tools, personalised treatments and quality of life — as fast as possible; to increase the availability of biological and clinical resources to researchers; to develop clinical trials, especially new molecular-driven trials tailored to targeted therapies and more broadly to innovations in drugs or technologies; to strengthen france’s leading position in personalised medicine. public health to improve knowledge on cancer risk factors; to continuously enhance the organisation of screening, by assessing and incorporating scientific and technical advances; to define and adapt screening strategies according to people’s level of cancer risk; to provide information on the different screening modalities; to provide open access to cancer data. cancer care to guarantee equal access to safe, high-quality care; to develop relevant care procedures for people with rare cancers, people with a genetic predisposition, elderly people, children and teenagers; to support therapeutic and technological developments, and career paths in oncology; to inform and support patients, their relatives and friends, through a range of services (e-cancer website, guides, hotline); to foster improvements in the quality of life during and after the disease. our resources the institute board of directors is made up of representatives of the core gip members and of eight qualified individuals. it is supported by an international scientific advisory board and three consultative bodies: an ethics committee; an audit committee; a users and professionals committee (comup). the institute has an annual budget of approximately €100 million . most of it is provided by the ministries for health and for research, contributions from other gip members and funds from partnerships with public and private organisations. about half of this budget is allocated to research funding. the rest is allocated to healthcare initiatives, public health and public information. the institute has ca. 150 employees and works with several hundred outside experts each year. documents to download national cancer institute presentation booklet - pdf 145.13 ko summary - the 2014-2019 cancer plan contact us follow us
Informations Whois
Whois est un protocole qui permet d'accéder aux informations d'enregistrement.Vous pouvez atteindre quand le site Web a été enregistré, quand il va expirer, quelles sont les coordonnées du site avec les informations suivantes. En un mot, il comprend ces informations;
%%
%% This is the AFNIC Whois server.
%%
%% complete date format : DD/MM/YYYY
%% short date format : DD/MM
%% version : FRNIC-2.5
%%
%% Rights restricted by copyright.
%% See https://www.afnic.fr/en/products-and-services/services/whois/whois-special-notice/
%%
%% Use '-h' option to obtain more information about this service.
%%
%% [2600:3c03:0000:0000:f03c:91ff:feae:779d REQUEST] >> e-cancer.fr
%%
%% RL Net [##########] - RL IP [######....]
%%
domain: e-cancer.fr
status: ACTIVE
hold: NO
holder-c: INDC39-FRNIC
admin-c: CFH1-FRNIC
tech-c: CFH1-FRNIC
zone-c: NFC1-FRNIC
nsl-id: NSL20484-FRNIC
registrar: CLARANET SAS
Expiry Date: 09/10/2017
created: 21/09/2007
last-update: 09/10/2016
source: FRNIC
ns-list: NSL20484-FRNIC
nserver: ns0.fr.claradns.net
nserver: ns1.fr.claradns.net
nserver: ns2.fr.claradns.net
source: FRNIC
registrar: CLARANET SAS
type: Isp Option 1
address: 18-20, rue du Faubourg du Temple
address: PARIS
country: FR
phone: +33 1 70 13 70 00
fax-no: +33 1 70 13 70 01
e-mail: sophie.pacave@fr.clara.net
website: http://www.claranetsoho.fr
anonymous: NO
registered: 08/10/1998
source: FRNIC
nic-hdl: INDC39-FRNIC
type: ORGANIZATION
contact: INSTITUT NATIONAL DU CANCER
address: 21, rue Leblanc
address: le Ponant B
address: 75740 Paris Cedex 15
country: FR
phone: +33 1 41 10 70 41
e-mail: lloupiac@institutcancer.fr
registrar: CLARANET SAS
changed: 10/10/2014 nic@nic.fr
anonymous: NO
obsoleted: NO
eligstatus: ok
eligdate: 10/10/2014 00:07:17
source: FRNIC
nic-hdl: CFH1-FRNIC
type: ROLE
contact: Claranet France Hostmaster
address: 68, rue du faubourg Saint Honoré
address: 75008 Paris
country: FR
phone: +33 1 70 13 70 00
fax-no: +33 1 70 13 70 01
e-mail: noc@fr.clara.net
admin-c: EL1447-FRNIC
tech-c: CH309-FRNIC
tech-c: EL1447-FRNIC
notify: noc@fr.clara.net
registrar: CLARANET SAS
changed: 07/10/2003 tom@fr.clara.net
anonymous: NO
obsoleted: NO
source: FRNIC
REFERRER http://www.nic.fr
REGISTRAR AFNIC
SERVERS
SERVER fr.whois-servers.net
ARGS e-cancer.fr
PORT 43
TYPE domain
RegrInfo
DISCLAIMER
%
% This is the AFNIC Whois server.
%
% complete date format : DD/MM/YYYY
% short date format : DD/MM
% version : FRNIC-2.5
%
% Rights restricted by copyright.
% See https://www.afnic.fr/en/products-and-services/services/whois/whois-special-notice/
%
% Use '-h' option to obtain more information about this service.
%
% [2600:3c03:0000:0000:f03c:91ff:feae:779d REQUEST] >> e-cancer.fr
%
% RL Net [##########] - RL IP [######....]
%
REGISTERED yes
ADMIN
HANDLE CFH1-FRNIC
TYPE ROLE
CONTACT Claranet France Hostmaster
ADDRESS
68, rue du faubourg Saint Honoré
75008 Paris
COUNTRY FR
PHONE +33 1 70 13 70 00
FAX +33 1 70 13 70 01
EMAIL noc@fr.clara.net
ADMIN-C EL1447-FRNIC
TECH-C
CH309-FRNIC
EL1447-FRNIC
NOTIFY noc@fr.clara.net
SPONSOR CLARANET SAS
CHANGED 2003-10-07
ANONYMOUS NO
OBSOLETED NO
SOURCE FRNIC
TECH
HANDLE CFH1-FRNIC
TYPE ROLE
CONTACT Claranet France Hostmaster
ADDRESS
68, rue du faubourg Saint Honoré
75008 Paris
COUNTRY FR
PHONE +33 1 70 13 70 00
FAX +33 1 70 13 70 01
EMAIL noc@fr.clara.net
ADMIN-C EL1447-FRNIC
TECH-C
CH309-FRNIC
EL1447-FRNIC
NOTIFY noc@fr.clara.net
SPONSOR CLARANET SAS
CHANGED 2003-10-07
ANONYMOUS NO
OBSOLETED NO
SOURCE FRNIC
OWNER
HANDLE INDC39-FRNIC
TYPE ORGANIZATION
CONTACT INSTITUT NATIONAL DU CANCER
ADDRESS
21, rue Leblanc
le Ponant B
75740 Paris Cedex 15
COUNTRY FR
PHONE +33 1 41 10 70 41
EMAIL lloupiac@institutcancer.fr
SPONSOR CLARANET SAS
CHANGED 2014-10-10
ANONYMOUS NO
OBSOLETED NO
ELIGSTATUS ok
ELIGDATE 10/10/2014 00:07:17
SOURCE FRNIC
DOMAIN
STATUS ACTIVE
HOLD NO
SPONSOR CLARANET SAS
EXPIRY DATE 09/10/2017
CREATED 2007-09-21
CHANGED 2016-10-09
SOURCE FRNIC
HANDLE NSL20484-FRNIC
NSERVER
NS0.FR.CLARADNS.NET 195.245.201.53
NS1.FR.CLARADNS.NET 194.112.32.53
NS2.FR.CLARADNS.NET 195.8.69.53
NAME e-cancer.fr
Go to top
en.e-cancer.fr rapport :
Visitez le site
